S. Landi

In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer.

A. Pinchera, P. Vitti, F. Gemignani, 2011, Endocrine-related cancer.

Genetic polymorphisms associated with outcome in multiple myeloma patients receiving high-dose melphalan

S. Tavtigian, T. Reiman, R. Barale, 2010, Bone Marrow Transplantation.

Characterization of novel 3′untranslated regions and related polymorphisms of the gene NPPC, encoding for the C-type natriuretic peptide

F. Gemignani, D. Giannessi, S. Ry, 2013, Peptides.

Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study

J. Chang-Claude, F. Clavel-Chapelon, F. Berrino, 2006, British Journal of Cancer.

Expression of gene MAGE-A4 in Reed-Sternberg cells.

L. Xerri, D. Olive, P. Coulie, 2000, Blood.

Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium.

U. Vogel, V. Moreno, D. Campa, 2015, Endocrine-related cancer.

Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case–control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium

D. Campa, F. Canzian, R. Reis, 2012, Leukemia.

Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case—control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium

D. Campa, F. Canzian, R. Reis, 2013, Leukemia.